Cherry Hill Sales Recalls MakeSense First Aid Cream Due to CGMP Deviations
Cherry Hill Sales Co. is voluntarily recalling 7,200 cartons of MakeSense First Aid Cream due to Current Good Manufacturing Practice (CGMP) deviations.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to CGMP deviations, which typically indicates a theoretical risk of harm rather than reported injuries, aligning with the Moderate severity criteria for voluntary precautionary recalls.
Plain-English summary
Cherry Hill Sales Co. is voluntarily recalling 7,200 cartons of MakeSense PHARMA FIRST AID CREAM, NDC 69020-210-28. The product is a 1 oz (28 g) tube containing Lidocaine HCL 0.5% and Phenol 0.5%, manufactured in China and distributed by Cherry Hill Associates in Chesapeake, VA. The recall was initiated on January 27, 2017, and was classified as Class II by the FDA.
The reason for the recall is Current Good Manufacturing Practice (CGMP) deviations. The affected lots are Lot # 103814 (Exp. 09/17) and Lot # 105306 (Exp. 04/18). The product was distributed in Michigan, Illinois, New York, Florida, and Pennsylvania. The recall status is Terminated as of April 19, 2017.
Consumers who have this product should stop using it and contact Cherry Hill Sales Co. for further instructions. The recall was initiated by the firm and notified via telephone.
The recalled product
- Product
- MakeSense PHARMA FIRST AID CREAM Lidocaine HCL 0.5%, Phenol 0.5%, 1 oz.. (28 g) tube, Made in China, Distributed by Cherry Hill Associates, Chesapeake, VA 23320, NDC 69020-210-28
- Manufacturer
- Cherry Hill Sales Co.
- Category
- Drug — Topical Analgesic
- Hazard
- Affected units
- 7,200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # 103814
- Exp. 09/17 Lot # 105306
- Exp. 04/18 NDC 69020-210-28 UPC 85718005139
Distribution
Part of a larger recall action
This product is one of 5 recalled by Cherry Hill Sales Co. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Cherry Hill Sales Co.
See all →- ModerateCherry Hill Sales Recalls MakeSense Antifungal Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Hemorrhoidal Cream Due to Manufacturing Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Medicated Anti-Itch Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
- ModerateCherry Hill Sales Recalls Clotrimazole Antifungal Cream Due to CGMP Deviations
FDA (Drugs) · 2017-03-01
Same hazard · cgmp deviation
See all →- SevereBaxter Recalls Vasopressin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- HighBaxter Recalls Clindamycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
- ModerateLexia LLC Recalls Broadway Joe's Pain Cream Due to CGMP Deviations
FDA (Drugs) · 2026-09-09
- SevereBaxter Recalls Daptomycin Injection Due to Manufacturing Deviations
FDA (Drugs) · 2026-09-09
Similar recalls
- ModerateCVS Health Natural Sleep Aid Chewable Tablets Recalled for Manufacturing Deviations
FDA (Drugs) · 2022-02-09
- ModerateDrug Recall: Cold Relief Tablets Due to cGMP Deviations
FDA (Drugs) · 2022-02-09
- HighFDA Recalls Premier Value Nasal Decongestant Due to Manufacturing Deviations
FDA (Drugs) · 2018-10-24
- High
- ModerateCold Tablet with Acetaminophen Recalled for cGMP Deviations
FDA (Drugs) · 2022-02-09
- SevereLongbow Recalls Emergency First Aid Eyewash Due to Manufacturing Deviations
FDA (Drugs) · 2018-08-15